Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Amortizatization of Intangibles came in at $1.6 million in Q1 2026, up 2033.87% year-over-year from $74226.0 in Q1 2025, and down 73.59% quarter-over-quarter from $6.0 million in Q4 2025.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Amortizatization of Intangibles for 2 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 2033.87% year-over-year to $1.6 million in Q1 2026; TTM through Jun 2026 was $7.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.0 million, up 5667.23% from the prior year.
- Amortizatization of Intangibles was $1.6 million for Q1 2026 at Aspire Biopharma Holdings, down from $6.0 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $6.0 million in Q4 2025 and troughed at $68733.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.39 Mn |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 363,567.00 |
| Jun 30, 2025 | 68,733.00 |
| Mar 31, 2025 | 74,226.00 |